COVID-19 in Nursing Homes 2020 and 2021

To describe the effect on mortality in nursing home facilities during three separate equally long periods during the pandemic and more specifically to analyse the effect on mortality of improved preventive routines and vaccination.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Comorbidities and Coexisting Conditions COVID-19 Coronaviridae Infections Coronavirus Infections Covid19 Frailty Infections Lung Diseases Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Anestesi- och operationskliniken, Universitetssjukhuset

Linköping, SE-581 85, Sweden

About this study

Retrospective descriptive cohort study in Östergötland County Council, Sweden comprising 136 nursing home facilities with a possibility to host 4500 residents. All residents in any of these NHs who had a laboratory confirmed COVID-19 diagnosis between March 2020 to April 2021 and who died within 30 days after the verified diagnosis are included. The study is undertaken as a retrospective record review. From the records patient-level data on demographic variables, clinical signs, comorbidity, performance status, and cause of death are collected.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All residents in any of 136 nursing homes in Östergötland County Council, Sweden who had a laboratory confirmed COVID-19 diagnosis and who died within 30 days after the verified COVID-19 were included in three separate periods: First period from March 31 to June 30 2020; second period from October 15 2020 to January 15 2021; third period from January 16 to April 18 2021.

Exclusion criteria

Treatment and study plan

Primary outcomes

Comorbidity

Time frame: March 2020 to April 2021

Number of diagnoses bedisde COVID-19
Frailty

Time frame: March 2020 to April 2021

The combined assessment of performance status and frailty was adapted to the record review method
Cause of death

Time frame: March 2020 to April 2021

assessment of cause of death

Sponsors and collaborators

Lead sponsor

Lena Nilsson

Other

Collaborators

Region Östergötland

Registry information

Official study title

Association Between COVID-19 Vaccination and Reduced Mortality in Nursing Home Facilities.

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Jun 30, 2021
Registry last updated: Jul 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed